Simplifying & Diversifying the Toolkits to Evaluate the Targeting Efficiency & Early Preclinical Dosimetry of Novel TRPs
Time: 10:00 am
day: Conference Day One
Details:
- When testing new TRPs on a preclinical stage, time and quantity matter
- Exploring new technologies allowing for more diverse testing methods in PK analysis, with accurate results in shorter experimental times
- Outlining available tools, their benefits and limitations and CROs statistical analysis of what pharma companies choose for their PK studies
